Flourish Health — $26M Series A
Led by B Capital, F-Prime, and Cherryrock Capital. Combined with previously undisclosed prior financing, total reaches $46M. Psychiatrist-led pediatric behavioral health for serious and complex needs, ages 8–26.
Company
Round
Series A
Amount
$26M
Total Raised
$46M
Date
July 27, 2026
HQ
Richmond, VA
Lead Investors
B Capital, F-Prime, Cherryrock Capital
The Deal
Flourish Health announced a $26M Series A on July 27, 2026, led by B Capital, F-Prime, and Cherryrock Capital. Combined with a previously undisclosed prior financing, the round brings total funding to $46M. The Richmond-based company provides psychiatrist-led, in-home and virtual mental health care for young people with serious and complex needs (ages 8–26), and said the new capital will fund national expansion through partnerships with large health plans.
Context
This is the fourth pediatric behavioral health round of the summer alongside Handspring Health, InStride Health, and Ladder Health, making the category the only lane in maternal-pediatric health clearing the financing bar with any consistency. Flourish is not a marketplace. It is a higher-intensity care-delivery business for kids who might otherwise cycle through hospitalization, residential treatment, or long waitlists. The strategic tell is payer mix: Flourish works with major health plans, Medicaid plans, and value-based contracts, which makes this a reimbursement and care-model bet, not just a demand story. That broader payer exposure distinguishes it from Handspring, which is primarily commercial/commercial-insurance.